​

HeartBeam Stock (NASDAQ:BEAT)

ForecastOwnershipFinancialsChartTranscripts
HeartBeam by TradingView

Previous Close

$0.90

52W Range

$0.54 - $4.00

50D Avg

$1.23

200D Avg

$1.50

Market Cap

$30.31M

Avg Vol (3M)

$1.47M

Beta

-0.64

Div Yield

-

BEAT Company Profile

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

21

IPO Date

Nov 11, 2021

Website

BEAT Performance

BEAT Financial Summary

Dec 25Dec 24Dec 23
Revenue---
Operating Income$-21.14M$-19.89M$-15.31M
Net Income$-21.02M$-19.45M$-14.64M
EBITDA$-21.14M$-19.88M$675.00K
Basic EPS$-0.62$-0.73$-0.72
Diluted EPS$-0.62$-0.73$-0.72

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Mar 12, 26 | 4:30 PM
Q3 25Nov 13, 25 | 4:30 PM
Q2 25Aug 13, 25 | 4:30 PM

Peer Comparison

TickerCompany
OSTXOS Therapies Incorporated
OTLKOutlook Therapeutics, Inc.
INKTMiNK Therapeutics, Inc.
CRVOCervoMed Inc.
SPRBSpruce Biosciences, Inc.
IOBTIO Biotech, Inc.
EQEquillium, Inc.
HOWLWerewolf Therapeutics, Inc.
MDAISpectral AI, Inc.
ONMDOneMedNet Corporation